ID:MUC21_HUMAN DESCRIPTION: RecName: Full=Mucin-21; Short=MUC-21; AltName: Full=Epiglycanin; Flags: Precursor; SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein; Extracellular side. TISSUE SPECIFICITY: Expressed in lung, large intestine, thymus, and testis. Expressed in normal and malignant bronchial epithelial cells. PTM: O-glycosylated. MISCELLANEOUS: Could be considered as a marker for lung carcinomas. SEQUENCE CAUTION: Sequence=AAI05737.1; Type=Erroneous initiation; Note=Translation N-terminally extended; WEB RESOURCE: Name=Mucin database; URL="http://www.medkem.gu.se/mucinbiology/databases/";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
Protein Domain and Structure Information
Pfam Domains: PF05647 - Tandem-repeating region of mucin, epiglycanin-like PF14654 - Mucin, catalytic, TM and cytoplasmic tail region
ModBase Predicted Comparative 3D Structure on Q5SSG8
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
AK299471 - Homo sapiens cDNA FLJ50027 complete cds, weakly similar to Dentin sialophosphoprotein precursor. AK316363 - Homo sapiens cDNA, FLJ79262 complete cds, weakly similar to Dentin sialophosphoprotein precursor. AK298642 - Homo sapiens cDNA FLJ56824 complete cds, weakly similar to Dentin sialophosphoprotein precursor. AY358415 - Homo sapiens clone DNA66674 KMQK697 (UNQ697) mRNA, complete cds. BC105735 - Homo sapiens mucin 21, cell surface associated, mRNA (cDNA clone MGC:125612 IMAGE:40026480), complete cds. BC105736 - Homo sapiens mucin 21, cell surface associated, mRNA (cDNA clone IMAGE:40026479), complete cds. BC105737 - Homo sapiens mucin 21, cell surface associated, mRNA (cDNA clone MGC:125610 IMAGE:40026476), complete cds. BC107478 - Homo sapiens mucin 21, cell surface associated, mRNA (cDNA clone MGC:125609 IMAGE:40026469), complete cds. HM596784 - Homo sapiens epiglycanin (MUC21) mRNA, complete cds. AB242595 - Homo sapiens MUC21 mRNA for mucin 21, complete cds. KJ905669 - Synthetic construct Homo sapiens clone ccsbBroadEn_15325 MUC21 gene, encodes complete protein. AK301645 - Homo sapiens cDNA FLJ54412 complete cds, moderately similar to Homo sapiens dentin sialophosphoprotein (DSPP), mRNA. JD371053 - Sequence 352077 from Patent EP1572962. JD321809 - Sequence 302833 from Patent EP1572962. JD321809 - Sequence 302833 from Patent EP1572962. JD371053 - Sequence 352077 from Patent EP1572962. JD321809 - Sequence 302833 from Patent EP1572962. AK056612 - Homo sapiens cDNA FLJ32050 fis, clone NTONG2001222. JD321809 - Sequence 302833 from Patent EP1572962. JD544031 - Sequence 525055 from Patent EP1572962. JD371053 - Sequence 352077 from Patent EP1572962. JD187588 - Sequence 168612 from Patent EP1572962. JD532548 - Sequence 513572 from Patent EP1572962. JD556550 - Sequence 537574 from Patent EP1572962. JD514750 - Sequence 495774 from Patent EP1572962. JD078461 - Sequence 59485 from Patent EP1572962. JD486816 - Sequence 467840 from Patent EP1572962. JD082405 - Sequence 63429 from Patent EP1572962. JD043234 - Sequence 24258 from Patent EP1572962. JD054736 - Sequence 35760 from Patent EP1572962. JD175102 - Sequence 156126 from Patent EP1572962. JD243864 - Sequence 224888 from Patent EP1572962. JD176333 - Sequence 157357 from Patent EP1572962. JD043649 - Sequence 24673 from Patent EP1572962. JD054161 - Sequence 35185 from Patent EP1572962. JD297539 - Sequence 278563 from Patent EP1572962. JD488517 - Sequence 469541 from Patent EP1572962. JD462717 - Sequence 443741 from Patent EP1572962. JD349212 - Sequence 330236 from Patent EP1572962. JD086936 - Sequence 67960 from Patent EP1572962. JD299494 - Sequence 280518 from Patent EP1572962. JD082070 - Sequence 63094 from Patent EP1572962. JD546213 - Sequence 527237 from Patent EP1572962. JD337911 - Sequence 318935 from Patent EP1572962. JD463965 - Sequence 444989 from Patent EP1572962. JD250512 - Sequence 231536 from Patent EP1572962. JD292710 - Sequence 273734 from Patent EP1572962. JD535529 - Sequence 516553 from Patent EP1572962. JD425942 - Sequence 406966 from Patent EP1572962. JD424940 - Sequence 405964 from Patent EP1572962. JD214949 - Sequence 195973 from Patent EP1572962. JD310961 - Sequence 291985 from Patent EP1572962. JD261676 - Sequence 242700 from Patent EP1572962. JD541536 - Sequence 522560 from Patent EP1572962. JD238909 - Sequence 219933 from Patent EP1572962. JD374419 - Sequence 355443 from Patent EP1572962. JD549039 - Sequence 530063 from Patent EP1572962. JD334501 - Sequence 315525 from Patent EP1572962. JD332936 - Sequence 313960 from Patent EP1572962. JD089177 - Sequence 70201 from Patent EP1572962. JD490175 - Sequence 471199 from Patent EP1572962. JD501386 - Sequence 482410 from Patent EP1572962.
Biochemical and Signaling Pathways
Reactome (by CSHL, EBI, and GO)
Protein Q5SSG8 (Reactome details) participates in the following event(s):
R-HSA-913675 GALNTs transfer GalNAc from UDP-GalNAc to mucins to form Tn antigens R-HSA-5694487 A4GNT transfers GlcNAc to core 2 mucins R-HSA-6786012 CHST4 transfers SO4(2-) from PAPS to Core 2 mucins R-HSA-914012 GCNTs transfer GlcNAc from UDP-GlcNAc to Core 1 mucins R-HSA-914018 Addition of GlcNAc to Core 3 forms a Core 4 glycoprotein R-HSA-977228 Sialyltransferase I can add sialic acid to the T antigen at the alpha 6 position R-HSA-981497 ST3GAL1-4 can add a sialic acid to the T antigen at the alpha 3 position R-HSA-981814 GalNAc alpha-2,6-sialyltransferase II can add a sialic acid to the T antigen at the alpha 6 position R-HSA-1964505 C1GALT1 transfers Galactose to the Tn antigen forming Core 1 glycoproteins (T antigens) R-HSA-1964501 Addition of galactose to Core 6 glycoprotein R-HSA-914010 Addition of GlcNAc to the Tn antigen forms a Core 3 glycoprotein R-HSA-977071 Sialyltransferase I can add sialic acid to the Tn antigen at the alpha 6 position R-HSA-981809 ST6GALNAC3/4 can add a sialic acid to the sialyl T antigen to form the disialyl T antigen R-HSA-8858500 CLEC10A binds Tn-MUC1 R-HSA-913709 O-linked glycosylation of mucins R-HSA-5083636 Defective GALNT12 causes colorectal cancer 1 (CRCS1) R-HSA-5083625 Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) R-HSA-977068 Termination of O-glycan biosynthesis R-HSA-5083632 Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) R-HSA-5621480 Dectin-2 family R-HSA-5173105 O-linked glycosylation R-HSA-3906995 Diseases associated with O-glycosylation of proteins R-HSA-5621481 C-type lectin receptors (CLRs) R-HSA-597592 Post-translational protein modification R-HSA-3781865 Diseases of glycosylation R-HSA-168249 Innate Immune System R-HSA-392499 Metabolism of proteins R-HSA-1643685 Disease R-HSA-168256 Immune System